Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here’s Why Lilly Stock Just Hit A Record

Feb 5, 2024
amgen-is-trying-to-take-on-lilly,-novo-in-obesity-treatment-—-here’s-why-lilly-stock-just-hit-a-record

Amgen stock slumped Monday — as Eli Lilly stock hit a record high — after the company unveiled preclinical results for its weight-loss drug.

Leave a comment